Ackman: Uncertainty on Valeant will be over in weeks
March 01, 2016 at 00:05 AM EST
Investor Bill Ackman told CNBC he expected under-fire pharma company Valeant to take just weeks to sort out the issues hammering its share price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.